CVS Health Corporation (CVS)
Last Price$64.9(1.2%)
Market Cap$82.3B
CVS Rating
CVS Quality rating performance
CVS Intrinsic Value
Key Highlights:
As of Mar 03, 2025 CVS Relative Value is $57.9, which is overvalued by 10.8%, compared to current share price of $64.9.
As of Mar 03, 2025 CVS DCF Value is $358.6, which is undervalued by 452.5%, compared to current share price of $64.9.
CVS Share Price History
1W 3.0%
1M 16.0%
6M 14.4%
YTD (16.4%)
1Y (9.3%)
3Y (32.1%)
5Y 19.9%
10Y (18.1%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
CVS Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$82.3B
$154.3B
$372.8B
$6,326.0M
Shares Outstanding
1,269M
Employees
300K
Growth (CAGR)
7.7%
(6.6%)
(6.34%)
(9.4%)
61.92%
Profitability
13.8%
2.3%
2.4%
1.7%
137.9%
Intrinsic Value
$208.2 (220.8% undervalued)
$356.4
$59.9
$150.2
$216.9
142.1%
Return on Capital
Financial Health
$71.9B
11.4x
2.9x
109.5%
Dividends
9.3%
4.1%
53.3%
Jan 23, 2025
Earnings
Apr 29, 2025
BEAT by 2.8%
MISS by (32.1%)
16.0%
8 Beat & 2 Miss
CVS Stock Financials
CVS Income Statement Metrics
Annual
Quarterly
LTM
CVS Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$9,107.0M -32.2% YoY
Capital Expenditure (CAPEX)
($2,781.0M) -8.2% YoY
Free Cash Flow (FCF)
$6,326.0M -39.1% YoY
CVS Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$372.8B 4.2% YoY
Cost of revenue
$321.4B 6.0% YoY
Pre-tax income
$6,148.0M (45.0%) YoY
1.6% margin
CVS Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$253.2B
Current assets ($68.6B, 27.1% of total)
$11.0B (4.3%)
$36.5B (14.4%)
Other current assets
$21.2B (8.4%)
Non-current assets ($184.6B, 72.9% of total)
$28.9B (11.4%)
$28.9B (11.4%)
$27.3B (10.8%)
Other non-current assets
$99.4B (39.2%)
Financial position
$71.9B
Cash & Short-term
Investments
Total Debt
CVS Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
CVS Earnings Surprises
Crunching data... Almost there!
CVS Dividends
CVS Dividend Yield
Crunching data... Almost there!
CVS Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with CVS
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$82.3B | 5.1 | $208.2 220.8% undervalued | (9.3%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$436.0B | 5.9 | $1,047.3 124.2% undervalued | (1.6%) | $398.3B | $20.7B | 8.4% | 5.2% | 21.9% | 28.1% | 1.5% | |
$90.7B | 6.7 | $1,001.8 153.3% undervalued | (20.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 43.4% | 161.3% | 4.9% | |
$87.2B | 5.8 | $942.9 202.7% undervalued | (6.0%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$31.5B | 6.1 | $797.8 205.0% undervalued | (23.7%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 91.9% | 58.6% | 71.3% | |
$29.1B | 5.4 | $1,406.9 2,301.3% undervalued | (25.2%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 12.0% | 69.9% | |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$3,703.3M | 6.1 | $23.7 57.0% undervalued | (1.7%) | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (15.2%) | 29.5% | |
$3,104.9M | 5.4 | $8.2 47.0% overvalued | 187.4% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 33.7% | (41.1%) | 7.8% | |
$1,871.6M | 5.2 | $2.0 45.3% overvalued | 330.8% | $1,370.6M | $128.3M | (32.4%) | 9.4% | 53.9% | 1.2% | 0.0% | |
$65.5M | 5.0 | $46.2 463.3% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
FAQ
What is CVS Health Corporation (CVS) stock rating?
As of today, CVS Health Corporation has a stock rating of 5 (out of 10), which is considered Good.
is CVS Health Corporation (CVS) a good stock to buy?
As of today, CVS Health Corporation has a Good stock rating, which is 220.8% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.